Drug profile · INN
betamethasone
CELESTONE
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
betamethasone (CELESTONE) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN betamethasone
Brand CELESTONE
Route TOPICAL
Formulation TABLET
Related patents
Search patents →Frequently asked questions
What is betamethasone?
betamethasone (CELESTONE) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for betamethasone?
CELESTONE is a marketed brand name for betamethasone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of betamethasone?
betamethasone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.